Pharmacokinetics of levofloxacin following intravenous and subcutaneous administration in sheep

Asian Journal of Animal and Veterinary Advances

Volumn 7, Issue 1, 2012, Pages 85-93

  Patel, Urvesh D ^a   Patel, Jatin H ^b   Bhavsar, Shailesh K ^b   Thaker, Aswin M ^c  

^a JUNAGADH AGRICULTURAL UNIVERSITY   (India)

^b Dau Shri Vasudev Chandrakar Kamdhenu Vishwavidyalaya   (India)

^c NAVSARI AGRICULTURAL UNIVERSITY   (India)

Author keywords

Antibacterial drug; Fluroquinolone; Intravenous and subcutaneous administration; Levofloxacin; Pharmacokinetics; Sheep

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); OVIS ARIES;

EID: 84855169821     PISSN: 16839919     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajava.2012.85.93     Document Type: Article

References (45)

1. Aigbekaen, B.O. and C.E. Oshoma, 2010. Isolation of Enterobacter sakazakii from powdered foods locally consumed in Nigeria. Pak. J. Nutr., 9: 659-663.
2. Albarellos, G.A., L.A. Ambros and M.F. Landoni, 2005. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats. J. Vet. Pharmacal. Ther., 28: 363-369.
3. Bakken, J.S., 2004. The fluoroquinolones: How long will their utility last? Scand. J. Infect. Dis., 36: 85-92.
4. Blondeau, J.M., 1999. Expanded activity and utility of the new fluoroquinolones: A review. Clin. Ther., 21: 3-40.
5. Carceles, C.M., E. Escudero, E. Fernandez-Varon and P. Marin, 2009. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep. Vet. J., 180: 343-347.
6. Davis, R. and H.M. Bryson, 1994. Levofloxacin: A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 47: 677-700.
7. Dudley, M.N., 1991. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to fluoroquinolones. Am. J. Med., 91: 45S-50S.
8. Dumka, V.K. and A.K. Srivastava, 2006. Pharmacokinetics, urinary excretion and dosing regimen of levofloxacin following a single intramuscular administration in cross bred calves. J. Vet. Sci., 7: 333-337.
9. Dumka, V.K., 2007. Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves. J. Vet. Sci., 8: 357-360.
10. Dumka, V.K. and A.K. Srivastava, 2007a. Disposition kinetics, urinary excretion and dosage regimen of levofloxacin formulation following single intravenous administration in crossbred calves. Vet. Res. Commun., 31: 873-879.
11. Dumka, V.K. and A.K. Srivastava, 2007b. Kinetic disposition, urinary excretion and dosage regimen of subcutaneously administered levofloxacin in cross bred calves. Iran. J. Vet. Res., 8: 313-318.
12. Dwivedi, V.K., A. Soni, A. Payasi, A. Ahmad, S.P. Singh and M. Chaudhary, 2011. Potentox reduces biochemical and inflammatory response in osteomyelitis infection. Int. J. Osteoporosis Metab. Disorders, 4: 26-36.
13. Escudero, E., C.M. Carceles, E. Fernandez-Varon, P. Marin and H. Benchaoui, 2007. Pharmacokinetics of danofloxacin 18% in lactating sheep and goats. J. Vet. Pharmacal. Ther., 30: 572-577.
14. Fish, D.N. and A.T. Chow, 1997. The clinical Pharmacokinetics of levofloxacin. Clin. Pharmacokinet., 32: 101-119.
15. Gibaldi, M. and D. Perrier, 1982. Noncompartmental Analysis Based on Statistical Moment Theory. In: Pharmacokinetics, Gibaldi, M. and D. Perrier (Eds.). 2nd Edn. Marcel Dekker, New York, USA., pp: 409-417.
16. Goudah, A., 2008. Disposition kinetics of moxifloxacin in lactating ewes. Vet. J., 178: 282-287.
17. Goudah, A., K. Abo-El-Sooud, J.H. Shim, H. C. Shin and A.M. Abd El-Aty, 2008. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration. J. Vet. Pharmacal. Ther., 31: 399-405.
18. Goudah, A., 2009. Pharmacokinetics of levofloxacin in male camels (Camelus dromedarius). J. Vet. Pharmacal. Ther., 2: 296-299.
19. Goudah, A. and K. Abo-El-Sooud, 2009. Pharmacokinetics, urinary excretion and milk penetration of levofloxacin in lactating goats. J. Vet. Pharmacal. Ther., 32: 101-104.
20. Goudah, A. and S. Hasabelnaby, 2010. Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration. Vet. Med. Int., 2010: 1-6.
21. Haritova, A, L. Lashev and D. Pashov, 2003. Pharmacokinetics of enrofloxacin in lactating sheep. Res. Vet. Sci., 74: 241-245.
22. Hurst, M., H.M. Lamb, L.J. Scott and D.P. Figgitt, 2002. Levofloxacin: An updated review of its use in the treatment of bacterial infections. Drugs, 62: 2127-2167.
23. Iqbal, R., M.A. Zia, T. Iqbal and F. Hussain, 2000. Biodisposition kinetics of levofloxacin in female vlounteers following oral administration. Pak. J. Biol. Sci., 3: 1484-1486.
24. Langtry, H.D. and H.M. Lamb, 1998. Levofloxacin: its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 56: 487-515.
25. Lode, H., K. Borner and P. Koeppe, 1998. Pharmacodynamics of fluoroquinolones. Clin. Infect. Dis., 27: 33-39.
26. Manikandan, S., S. Ganesapandian, M. Singh and A.K. Kumaraguru, 2011. Emerging of multidrug resistance human pathogens from urinary tract infections. Curr. Res. Bacterial., 4: 9-15.
27. Marin, P., E. Fernandez-Varo, E. Escudero and C.M. Carceles, 2007. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of difloxacin in sheep. Res. Vet. Sci., 83: 234-238.
28. Marshall, S.A. and R.N. Jones, 1993. In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone. Antimicrob. Agents Chemother., 37: 2747-2753.
29. Martinez, M., P. McDermott and R. Walker, 2006. Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals. Vet. J., 172: 10-28.
30. McKellar, Q.A., I.F. Gibson and R.Z. McCormack, 1998. Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharm. Drug Dispos., 19: 123-129.
31. Moniri, R. and K. Dastehgoli, 2007. Antimicrobial resistance among Escherichia coli strains isolated from healthy and septicemic chickens. Pak. J. Biol. Sci., 10: 2984-2987.
32. Naeem, M. and K.K.S. Rafiq, 2006. Determination of residues of quinolones in poultry products by high pressure liquid chromatography. J. Applied Sci., 6: 373-379.
33. Nightingale, C.H., E.M. Grant and R. Quintiliani, 2000. Pharmacodynamics and pharmacokinetics of levofloxacin. Chemother, 46: 6-14.
34. Okazaki, O., C. Kojima, H. Hakusui and M. Nakashima, 1991. Enantioselective disposition of ofloxacin in humans. Antimicrob. Agents Chemother., 35: 2106-2109.
35. Patel, H.B., S.K. Bhavsar, A.M. Thaker, N.S. Babu and K.N. Wadhwani, 2004. Pharmacokinetics of ciprofloxacin following intravenous and intramuscular administration in sheep. J. Vet. Pharmacal. Toxicol., 3: 35-38.
36. Rahal, A., A. Kumar, A.H. Ahmad, J.K. Malik and V. Ahuja, 2006. Pharmacokinetics of enrofloxacin in sheep following intravenous and subcutaneous administration. J. Vet. Pharmacal. Therap., 29: 321-324.
37. Rahal, A., A. Kumar, A.H. Ahmad and J.K. Malik, 2007. Pharmacokinetics of ciprofloxacin in sheep following intravenous and subcutaneous administration. Small Ruminant Res., 73: 242-245.
38. Ram, D., V.K. Dumka and K. Rajdeep, 2007. Disposition and dosage regimen of levofloxacin in buffalo calves after extravascular administration. Proceedings of the 7th Annual Conference of Indian Society of Veterinary Pharmacology and Toxicology, November, 2007, Pookut, India, pp: 62.
39. Ram, M., R. Prasad, V. Singh and B.K. Roy, 2008. Comparative pharmacokinetics of levofloxacin after single intravenous administration in healthy and mastitic goats. Proceedings of the 8th Annual Conference of Indian Society of Veterinary Pharmacology and Toxicology, November, 2008, Mathura, India, pp: 146.
40. Sheikh, M.A., S. Khanum, A. Ahmad, T. Iqbal, Z. Hydair and S. Naz, 2001. Study of protein binding of levofloxacin in human beings. J. Medical Sci., 1: 87-90.
41. Sheikh, N.W., A.S. Tripathi, V. Chitra, A. Choudhury and S.P. Dewani, 2010. Excretion of levofloxacin into saliva in renal failure rat model. Int. J. Pharmacal., 63: 944-949.
42. Swoboda, S., K. Oberdorfer, F. Klee, T. Hoppe-Tichy, H. von Baum and H.K. Geiss, 2003. Tissue and serum concentrations of levofloxacin 500 mg administered intravenously or orally for antibiotic prophylaxis in biliary surgery. J. Antimicrob. Chemother., 51: 459-462.
43. Varia, R.D., J.H. Patel, U.D. Patel, S.K. Bhavsar and A.M. Thaker, 2009. Disposition of levofloxacin following oral administration in broiler chickens. Israel J. Vet. Med., 64: 118-121.
44. Waheed, N., T. Iqbal, M.A. Sheikh and F.H. Khan, 2002. Renal clearance of endogenous creatinine and levofloxacin in male volunteers. J. Medical Sci., 2: 145-148.
45. Walker, R.D., 2000. The use of fluoroquinolones for companion animal antimicrobial therapy. Aus. Vet. J., 78: 84-90.